COVID-19 — Key Persons Directory
COVID-19 — Key Persons Directory
[edit | edit source]Government and Public Health Officials
[edit | edit source]Dr. Anthony Fauci
[edit | edit source]Director, National Institute of Allergy and Infectious Diseases (NIAID), 1984–2022; de facto public face of U.S. COVID-19 response. Oversaw NIAID grants to EcoHealth Alliance for WIV collaboration. Emails show he received preliminary assessments from virologists suggesting lab origin (January 31, 2020) and was involved in the teleconference preceding the Proximal Origin paper. Congressional investigators concluded he "promoted the false narrative that COVID-19 originated in nature." Retired December 2022.
Dr. Francis Collins
[edit | edit source]Director, National Institutes of Health (NIH), 1993–2021. Wrote email to Fauci characterizing Great Barrington Declaration authors as "fringe epidemiologists" and calling for a "devastating published takedown." Retired December 2021.
Dr. David Morens
[edit | edit source]Senior scientific advisor to Fauci at NIAID. Congressional investigators found he unlawfully deleted federal COVID-19 records; used personal email specifically to evade FOIA requests; shared nonpublic NIH grant information with EcoHealth's Peter Daszak. Likely lied to Congress on multiple occasions per House Select Subcommittee findings.
Dr. Peter Daszak
[edit | edit source]President, EcoHealth Alliance. British zoologist and virologist. Oversaw EcoHealth's NIH-funded collaboration with the WIV. Congressional investigators found he obstructed investigation; instructed staff to limit document production; doctored documents before releasing them to Congress; provided false statements to Congress. Participated in WHO-China origins investigation despite EcoHealth's WIV relationship.
Dr. Shi Zhengli
[edit | edit source]Director, Center for Emerging Infectious Diseases, Wuhan Institute of Virology. The world's foremost bat coronavirus researcher; collected and studied thousands of bat coronavirus samples. Her lab held the database deleted in September 2019. Has consistently stated SARS-CoV-2 was not related to her laboratory's work. Cannot be independently interviewed by Western investigators.
Dr. Tedros Adhanom Ghebreyesus
[edit | edit source]Director-General, World Health Organization (2017–present). Presided over WHO's COVID-19 response; praised China's transparency in the early weeks; declared the PHEIC on January 30, 2020; declared pandemic March 11, 2020. Faced criticism for deferring to China and for the inadequate WHO-China origins investigation.
Scientists
[edit | edit source]Dr. Kristian Andersen
[edit | edit source]Scripps Research Institute; lead author of "The Proximal Origin of SARS-CoV-2." Private emails show he expressed concerns about engineered features on January 31, 2020; six weeks later published paper dismissing lab origin. Has maintained the paper reflects genuine scientific analysis.
Dr. Jay Bhattacharya
[edit | edit source]Stanford University epidemiologist; co-author of the Great Barrington Declaration; subsequently named director of NIH by the Trump administration in 2025 — a significant reversal of the institutional trajectory that had labeled him "fringe."
Dr. Robert Malone
[edit | edit source]Scientist who contributed early research on mRNA transfection technology; became prominent vaccine skeptic; his Twitter account was suspended in December 2021 for COVID-19 policy claims; reinstated after Musk's acquisition; controversial figure within scientific community.
Congressional Investigators
[edit | edit source]Representative Brad Wenstrup (R-OH)
[edit | edit source]Chair, House Select Subcommittee on the Coronavirus Pandemic; oversaw the 2-year investigation culminating in the December 2024 final report.
Senator Richard Burr (R-NC)
[edit | edit source]Led Senate HELP Committee investigation into COVID origins; the resulting 302-page Senate report concluded lab leak was more likely.
Senator Rand Paul (R-KY)
[edit | edit source]Conducted the most sustained congressional challenge to Fauci on gain-of-function research and NIH oversight, across multiple congressional hearings 2021–2022.
